发明名称 ALPHA-GLUCOSIDASE INHIBITOR CONTAINING PYRAZOLONE-BASED COMPOUND OR ITS SALT
摘要 PROBLEM TO BE SOLVED: To obtain the subject inhibitor having excellentα-glucosidase inhibiting activities useful for treatment of metastatis of cancer, virus disease, diabetes mellitus, etc., by including a pyrazolone-based compound or its salt having a specific structure. SOLUTION: This inhibitor includes a pyrazolone-based compound of formula I (R<1> is an alkyl, phenyl, etc.; R<2> is H, a halogen, etc.) or its salt. The compound of formula I in which R<2> is a group of phenylcarbonylamino or R<1> is a group of alkylcarbonyloxyalkyl is the new one. 4,4-Dibromo-3-benzoylamino-1-phenyl-2- pyrazolin-5-one is preferable as the former and 4,4-dibromo-1-(2-acetoxyethyl)-3- methyl-2-pyrazolin-5-one is preferable as the latter. The compound of formula I is, for example, obtained by reacting a compound of formula II with a brominating agent such as bromine at 5-100 deg.C for 0.5-24hr. The daily dose of the compound of formula I is usually 50-5,000mg for an adult.
申请公布号 JPH1045588(A) 申请公布日期 1998.02.17
申请号 JP19960227471 申请日期 1996.08.08
申请人 ISHIHARA SANGYO KAISHA LTD 发明人 KATO FUMINORI;KIMURA HIROHIKO
分类号 C07D231/20;A61K31/415;A61K31/44;A61K31/4427;A61K31/505;A61P3/06;A61P3/08;A61P3/10;A61P29/00;A61P31/12;A61P35/00;A61P37/00;A61P37/06;A61P37/08;C07D401/04;C07D403/04;(IPC1-7):A61K31/415 主分类号 C07D231/20
代理机构 代理人
主权项
地址